PeopleBio Statistics

Total Valuation

PeopleBio has a market cap or net worth of KRW 64.46 billion. The enterprise value is 66.32 billion.

Market Cap	64.46B
Enterprise Value	66.32B

Important Dates

The next estimated earnings date is Tuesday, March 18, 2025.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

PeopleBio has 21.03 million shares outstanding. The number of shares has increased by 41.85% in one year.

Current Share Class	n/a
Shares Outstanding	21.03M
Shares Change (YoY)	+41.85%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.55%
Owned by Institutions (%)	n/a
Float	17.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.03
PB Ratio	0.02
P/TBV Ratio	9.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.39
EV / Sales	15.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.00

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 1.12.

Current Ratio	1.17
Quick Ratio	0.71
Debt / Equity	1.12
Debt / EBITDA	n/a
Debt / FCF	-0.78
Interest Coverage	-33.56

Financial Efficiency

Return on equity (ROE) is -287.35% and return on invested capital (ROIC) is -49.15%.

Return on Equity (ROE)	-287.35%
Return on Assets (ROA)	-28.32%
Return on Capital (ROIC)	-49.15%
Revenue Per Employee	66.25M
Profits Per Employee	-186.56M
Employee Count	66
Asset Turnover	0.15
Inventory Turnover	1.29

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.30% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+10.30%
50-Day Moving Average	3,895.80
200-Day Moving Average	3,459.75
Relative Strength Index (RSI)	33.45
Average Volume (20 Days)	484,023

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PeopleBio had revenue of KRW 4.37 billion and -12.31 billion in losses. Loss per share was -574.23.

Revenue	4.37B
Gross Profit	1.23B
Operating Income	-13.01B
Pretax Income	-13.75B
Net Income	-12.31B
EBITDA	-11.33B
EBIT	-13.01B
Loss Per Share	-574.23

Full Income Statement

Balance Sheet

The company has 8.26 billion in cash and 10.40 billion in debt, giving a net cash position of -2.15 billion or -102.07 per share.

Cash & Cash Equivalents	8.26B
Total Debt	10.40B
Net Cash	-2.15B
Net Cash Per Share	-102.07
Equity (Book Value)	9.31B
Book Value Per Share	165,932.19
Working Capital	2.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.92 billion and capital expenditures -341.10 million, giving a free cash flow of -13.27 billion.

Operating Cash Flow	-12.92B
Capital Expenditures	-341.10M
Free Cash Flow	-13.27B
FCF Per Share	-630.73

Full Cash Flow Statement

Margins

Gross margin is 28.06%, with operating and profit margins of -297.54% and -281.60%.

Gross Margin	28.06%
Operating Margin	-297.54%
Pretax Margin	-314.55%
Profit Margin	-281.60%
EBITDA Margin	-259.03%
EBIT Margin	-297.54%
FCF Margin	n/a

Dividends & Yields

PeopleBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.85%
Shareholder Yield	-41.85%
Earnings Yield	-18.74%
FCF Yield	-20.58%

Stock Splits

The last stock split was on October 23, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 23, 2023
Split Type	Forward
Split Ratio	1.2

Scores

PeopleBio has an Altman Z-Score of -2.77. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.77
Piotroski F-Score	n/a